Form 4: GeneDx Holdings Corp. CFO Kevin Feeley Reports Stock Transactions
SEC Form 4 Filing
Kevin Feeley, CFO of GeneDx Holdings Corp., reports the vesting and sale of Class A Common Stock to cover tax obligations.
Summary
- On March 26, 2025, Kevin Feeley, the CFO of GeneDx Holdings Corp., reported transactions involving Class A Common Stock.
- These transactions included the vesting of 16,250 restricted stock units (RSUs) and the subsequent sale of shares to cover tax withholding obligations.
- Feeley sold 8,418 shares at $95.6577 and 328 shares at $94.4037.
- Following these transactions, Feeley directly owns 15,996 shares of Class A Common Stock and 48,750 restricted stock units.
Sentiment
Score: 5
Explanation: Neutral sentiment as the document primarily reports routine stock transactions for tax purposes.
Future Outlook
The remaining restricted stock units will continue to vest annually, subject to the Reporting Person's continued service to the Issuer.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions, providing transparency to investors regarding the actions of company executives.
Stakeholder Impact
- The transactions have a minimal impact on stakeholders as they are related to tax obligations and do not represent a significant change in ownership.
Key Dates
| Date | Description |
|---|---|
| 03/26/2025 | Date of earliest transaction: vesting of RSUs and sale of shares. |
| 03/26/2025 | Commencement date for annual vesting of restricted stock units. |
| 03/28/2025 | Date of signature for the Form 4 filing. |
Keywords
GeneDx Holdings Corp, Kevin Feeley, CFO, Class A Common Stock, Restricted Stock Units, Form 4, SEC, Insider Trading, Vesting, Tax Withholding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.